Masahiro Abe
University of Tokushima, TOKUSHIMA, Japan
- This delegate is presenting an abstract at this event.

Masahiro Abe is professor of Department of Hematology, Endocrinology and Metabolism at Tokushima University Graduate School, and chief of Division of Hematology at Tokushima University Hospital. He graduated from Tokushima University School of Medicine in 1984, and belonged to the First Department of Internal Medicine in Tokushima University Hospital. In 1989-92, he studied the biology of multiple myeloma and AL amyloidosis as a visiting scientist at Human Immunology and Cancer Program at University of Tennessee Medical Center, Knoxville, TN, USA. Thereafter, he worked as a hematologist, and became clinical professor of Tokushima University Hospital in 2009 and professor of Tokushima University Graduate School in 2015. He has been studying to dissect the molecular mechanisms for formation of bone disease in myeloma and drug resistance in myeloma cells and their progenitors, and trying to develop innovative therapeutic strategies. He hosted as a president the 41th Annual Meeting of the Japanese Society of Myeloma in 2016.
Presentations this author is a contributor to:
Osteoclasts utilize TRAIL for their NF-κB activation, but TAK1 inhibition resumes TRAIL-induced apoptosis in osteoclasts (#119)
5:00 PM
Hirofumi Tenshin
Welcome Reception & ANZBMS Plenary Posters
Novel targets of treatment for myeloma-bone interaction (#91)
8:30 AM
Masahiro Abe
Cancer & bone